Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreHarness unparalleled healthcare data, advanced analytics, and cutting-edge technologies with our expertise to accelerate the development and commercialization of innovative medicines, enhancing patient lives.
Discover MoreBoost your innovation with IQVIA's expert team. Our comprehensive solutions integrate top-tier insights, technology, and expertise to maximize your asset's success in a competitive landscape.
Discover InnovationsNavigating MedTech's unique landscape: U.S. decision-making now rests with GPOs, IDNs, and payers, who demand solid value proof through rigorous outcomes analyses and pricing scrutiny.
Explore MedTechInvest in healthcare with confidence. Stay ahead of pharma and medical device trends using real-time, high-quality data. Access market insights, historical sales, prescription trends, and emerging product information for informed, risk-reduced decisions.
Access InsightsUnlock deeper health insights with unmatched data and innovative technology to enhance decision-making for your essential government programs.
Unlock InnovationsAccelerate digital innovation with our data-driven expertise in data science and healthcare, optimizing business processes for smarter decisions.
Navigate Health PlansLeverage digital innovation to cut costs, boost efficiency, and elevate patient engagement, all while enhancing quality and health outcomes.
Streamline DecisionsEnhance your ability to evaluate and forecast population risk swiftly and accurately by integrating unmatched data, expertise, and technology.
Uncover MoreTransform into a data-driven organization that enhances your specialty and showcases value to your members through digital transformation.
Explore NowA curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTS"Discover the future through our enlightening podcasts available in the United States.
EXPLORE PODCASTSBalancing the competing priorities of investing in research, services, fundraising, and running an effective organization has long been a challenge for patient organizations. In the COVID-19 era, when incomes have been hit while need for support and services has never been higher, we discuss how patient organization leaders are finding the balance and investing where they can have maximum impact for patient communities, now and in the future. With a particular focus on medical research funding, we also explored how these leaders are prioritizing investment of precious resources in a way that is informed both by the research landscape and patient views.
This paper is informed by a session at the 2022 IQVIA Patient Advocacy Summit which brought together leaders from medical research foundations, networks of research charities, patient foundations and organizations, and IQVIA experts to discuss approaches to prioritizing resource use for maximum impact.
Download this whitepaper to learn more.
Participants
Jennifer Farmer, CEO, Friedreich’s Ataxia Research Alliance (FARA) (USA)
Nicola Perrin, CEO, Association of Medical Research Charities (AMRC) (UK)
Cynthia Rice, Chief Mission Strategy Officer, The Juvenile Diabetes Research Foundation (JDRF) (USA)
Kristin Schneeman, Senior Director, FasterCures, Milken Institute (USA)
Sarah Johnson, Head of Patient Advocacy, EMEA, IQVIA